181 related articles for article (PubMed ID: 21162745)
1. Expression of BMI-1 and Mel-18 in breast tissue--a diagnostic marker in patients with breast cancer.
Riis ML; Lüders T; Nesbakken AJ; Vollan HS; Kristensen V; Bukholm IR
BMC Cancer; 2010 Dec; 10():686. PubMed ID: 21162745
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma.
Lu YW; Li J; Guo WJ
J Exp Clin Cancer Res; 2010 Nov; 29(1):143. PubMed ID: 21059209
[TBL] [Abstract][Full Text] [Related]
3. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.
Silva J; García JM; Peña C; García V; Domínguez G; Suárez D; Camacho FI; Espinosa R; Provencio M; España P; Bonilla F
Clin Cancer Res; 2006 Dec; 12(23):6929-36. PubMed ID: 17145810
[TBL] [Abstract][Full Text] [Related]
4. Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells.
Guo WJ; Zeng MS; Yadav A; Song LB; Guo BH; Band V; Dimri GP
Cancer Res; 2007 Jun; 67(11):5083-9. PubMed ID: 17545584
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic importance of overexpression of Bmi-1 mRNA in early breast cancers.
Saeki M; Kobayashi D; Tsuji N; Kuribayashi K; Watanabe N
Int J Oncol; 2009 Sep; 35(3):511-5. PubMed ID: 19639171
[TBL] [Abstract][Full Text] [Related]
6. Expression of Bmi-1 is a prognostic marker in bladder cancer.
Qin ZK; Yang JA; Ye YL; Zhang X; Xu LH; Zhou FJ; Han H; Liu ZW; Song LB; Zeng MS
BMC Cancer; 2009 Feb; 9():61. PubMed ID: 19228380
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
[TBL] [Abstract][Full Text] [Related]
8. Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients.
Choi YJ; Choi YL; Cho EY; Shin YK; Sung KW; Hwang YK; Lee SJ; Kong G; Lee JE; Kim JS; Kim JH; Yang JH; Nam SJ
Breast Cancer Res Treat; 2009 Jan; 113(1):83-93. PubMed ID: 18228133
[TBL] [Abstract][Full Text] [Related]
9. Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma.
Lv J; Cao XF; Ji L; Zhu B; Wang DD; Tao L; Li SQ
Med Oncol; 2012 Mar; 29(1):151-60. PubMed ID: 21259057
[TBL] [Abstract][Full Text] [Related]
10. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients.
Silva J; García V; García JM; Peña C; Domínguez G; Díaz R; Lorenzo Y; Hurtado A; Sánchez A; Bonilla F
Breast Cancer Res; 2007; 9(4):R55. PubMed ID: 17711569
[TBL] [Abstract][Full Text] [Related]
11. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS
Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221
[TBL] [Abstract][Full Text] [Related]
12. Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients.
Tripathi A; King C; de la Morenas A; Perry VK; Burke B; Antoine GA; Hirsch EF; Kavanah M; Mendez J; Stone M; Gerry NP; Lenburg ME; Rosenberg CL
Int J Cancer; 2008 Apr; 122(7):1557-66. PubMed ID: 18058819
[TBL] [Abstract][Full Text] [Related]
13. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.
Stark AM; Tongers K; Maass N; Mehdorn HM; Held-Feindt J
J Cancer Res Clin Oncol; 2005 Mar; 131(3):191-8. PubMed ID: 15592684
[TBL] [Abstract][Full Text] [Related]
14. Low expression of Mel-18 predicts poor prognosis in patients with breast cancer.
Guo BH; Zhang X; Zhang HZ; Lin HL; Feng Y; Shao JY; Huang WL; Kung HF; Zeng MS
Ann Oncol; 2010 Dec; 21(12):2361-2369. PubMed ID: 20444850
[TBL] [Abstract][Full Text] [Related]
15. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
Kumamoto H; Ohki K
J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
[TBL] [Abstract][Full Text] [Related]
16. Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays.
Sánchez-Beato M; Sánchez E; González-Carreró J; Morente M; Díez A; Sánchez-Verde L; Martín MC; Cigudosa JC; Vidal M; Piris MA
Mod Pathol; 2006 May; 19(5):684-94. PubMed ID: 16528373
[TBL] [Abstract][Full Text] [Related]
17. The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens.
Steele JC; Torr EE; Noakes KL; Kalk E; Moss PA; Reynolds GM; Hubscher SG; van Lohuizen M; Adams DH; Young LS
Br J Cancer; 2006 Nov; 95(9):1202-11. PubMed ID: 17024127
[TBL] [Abstract][Full Text] [Related]
18. Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer.
Lorentzen A; Lewinsky RH; Bornholdt J; Vogel LK; Mitchelmore C
BMC Cancer; 2011 Jan; 11():14. PubMed ID: 21226903
[TBL] [Abstract][Full Text] [Related]
19. Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer.
Li DW; Tang HM; Fan JW; Yan DW; Zhou CZ; Li SX; Wang XL; Peng ZH
J Cancer Res Clin Oncol; 2010 Jul; 136(7):997-1006. PubMed ID: 20024662
[TBL] [Abstract][Full Text] [Related]
20. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins.
Guo WJ; Datta S; Band V; Dimri GP
Mol Biol Cell; 2007 Feb; 18(2):536-46. PubMed ID: 17151361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
